IBDEI1B1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20858,1,4,0)
 ;;=4^Z59.6
 ;;^UTILITY(U,$J,358.3,20858,2)
 ;;=^5063135
 ;;^UTILITY(U,$J,358.3,20859,0)
 ;;=Z59.7^^95^1029^6
 ;;^UTILITY(U,$J,358.3,20859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20859,1,3,0)
 ;;=3^Insufficient Social Insurance/Welfare Support
 ;;^UTILITY(U,$J,358.3,20859,1,4,0)
 ;;=4^Z59.7
 ;;^UTILITY(U,$J,358.3,20859,2)
 ;;=^5063136
 ;;^UTILITY(U,$J,358.3,20860,0)
 ;;=Z59.9^^95^1029^4
 ;;^UTILITY(U,$J,358.3,20860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20860,1,3,0)
 ;;=3^Housing/Economic Problems,Unspec
 ;;^UTILITY(U,$J,358.3,20860,1,4,0)
 ;;=4^Z59.9
 ;;^UTILITY(U,$J,358.3,20860,2)
 ;;=^5063138
 ;;^UTILITY(U,$J,358.3,20861,0)
 ;;=G21.19^^95^1030^10
 ;;^UTILITY(U,$J,358.3,20861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20861,1,3,0)
 ;;=3^Medication-Induced Parkinsonism,Other
 ;;^UTILITY(U,$J,358.3,20861,1,4,0)
 ;;=4^G21.19
 ;;^UTILITY(U,$J,358.3,20861,2)
 ;;=^5003773
 ;;^UTILITY(U,$J,358.3,20862,0)
 ;;=G21.11^^95^1030^13
 ;;^UTILITY(U,$J,358.3,20862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20862,1,3,0)
 ;;=3^Neuroleptic-Induced Parkinsonism
 ;;^UTILITY(U,$J,358.3,20862,1,4,0)
 ;;=4^G21.11
 ;;^UTILITY(U,$J,358.3,20862,2)
 ;;=^5003772
 ;;^UTILITY(U,$J,358.3,20863,0)
 ;;=G24.01^^95^1030^15
 ;;^UTILITY(U,$J,358.3,20863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20863,1,3,0)
 ;;=3^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,20863,1,4,0)
 ;;=4^G24.01
 ;;^UTILITY(U,$J,358.3,20863,2)
 ;;=^5003784
 ;;^UTILITY(U,$J,358.3,20864,0)
 ;;=G24.09^^95^1030^16
 ;;^UTILITY(U,$J,358.3,20864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20864,1,3,0)
 ;;=3^Tardive Dystonia
 ;;^UTILITY(U,$J,358.3,20864,1,4,0)
 ;;=4^G24.09
 ;;^UTILITY(U,$J,358.3,20864,2)
 ;;=^5003786
 ;;^UTILITY(U,$J,358.3,20865,0)
 ;;=G25.1^^95^1030^11
 ;;^UTILITY(U,$J,358.3,20865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20865,1,3,0)
 ;;=3^Medication-Induced Postural Tremor
 ;;^UTILITY(U,$J,358.3,20865,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,20865,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,20866,0)
 ;;=G25.71^^95^1030^14
 ;;^UTILITY(U,$J,358.3,20866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20866,1,3,0)
 ;;=3^Tardive Akathisia
 ;;^UTILITY(U,$J,358.3,20866,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,20866,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,20867,0)
 ;;=G25.79^^95^1030^9
 ;;^UTILITY(U,$J,358.3,20867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20867,1,3,0)
 ;;=3^Medication-Induced Movement Disorder,Other
 ;;^UTILITY(U,$J,358.3,20867,1,4,0)
 ;;=4^G25.79
 ;;^UTILITY(U,$J,358.3,20867,2)
 ;;=^5003800
 ;;^UTILITY(U,$J,358.3,20868,0)
 ;;=T43.205A^^95^1030^4
 ;;^UTILITY(U,$J,358.3,20868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20868,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
 ;;^UTILITY(U,$J,358.3,20868,1,4,0)
 ;;=4^T43.205A
 ;;^UTILITY(U,$J,358.3,20868,2)
 ;;=^5050540
 ;;^UTILITY(U,$J,358.3,20869,0)
 ;;=T43.205D^^95^1030^5
 ;;^UTILITY(U,$J,358.3,20869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20869,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,20869,1,4,0)
 ;;=4^T43.205D
 ;;^UTILITY(U,$J,358.3,20869,2)
 ;;=^5050541
 ;;^UTILITY(U,$J,358.3,20870,0)
 ;;=T43.205S^^95^1030^6
 ;;^UTILITY(U,$J,358.3,20870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20870,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
 ;;^UTILITY(U,$J,358.3,20870,1,4,0)
 ;;=4^T43.205S
